All News

Found 772,514 articles

• Immunomedics, Inc. Reports Updated Clinical Results For Epratuzumab In Sjogren's Syndrome At The 2005 ACR/ARHP Annual Scientific Meeting

  11/15/2005

• Roche Release: Pegasys(R) Shows Encouraging Interim Results For Hepatitis C Patients in Whom Peg-Intron(R) Therapy Failed

  11/15/2005

• AstraZeneca Release: New Data Examines Effects Of CRESTOR(R) Alone Or In Combination With Another Therapy In High Risk Patients With Very High Cholesterol

  11/15/2005

• The International Myeloma Foundation Advocates Formal Approval Of Thalomid(R) For Multiple Myeloma

  11/15/2005

• PARI Aerosol Research Institute Issued US Patent For eFlow; Device Innovations Lead To Greater Efficiency In Drug Delivery

  11/15/2005

• Rincon Pharmaceuticals, Inc. Announces $4.7 Million Institutional Financing

  11/15/2005

• FzioMed Inc. Receives National Institutes of Health (NIH) Grant To Study Injectable Delivery Of Bone Growth Peptides For Spinal Fusion

  11/15/2005

• AVI BioPharma, Inc. Announces $22.6 Million Direct Equity Placement

  11/15/2005

• Boston Scientific Corporation Announces Pricing Of $750 Million Of Senior Notes

  11/15/2005

• Generex Biotechnology Corporation Achieves Compliance With Nasdaq Capital Market Continued Listing Requirements

  11/15/2005

• Anadys Pharmaceuticals, Inc. To Be Added To The NASDAQ Biotechnology Index (NBI)

  11/15/2005

• Immucor Common Stock To Resume Trading Under 'BLUD'

  11/15/2005

• Shareholders Of Wex Pharmaceuticals Inc. Call Special Meeting Of WEX Shareholders For January 12, 2006 For The Purpose Of Replacing The WEX Board Of Directors

  11/15/2005

• GlaxoSmithKline Is First Company Certified By NCQA In Program Design For Medication Adherence

  11/15/2005

• Epigenomics AG Announces End Of VC Pooling

  11/15/2005

• BSD Medical's Cancer Treatment Systems Get 37% Reimbursement Boost

  11/15/2005

• Elite Pharmaceuticals, Inc. Reviews Business Developments And Projected Corporate Milestones

  11/15/2005

• Omron Healthcare Co., Ltd. Develops Non-Invasive Augmentation Index Technology For Cardiovascular Disease Management

  11/15/2005

• U.S. BioDefense, Inc. Explores Strategic Response To Bird Flu Utilizing New Universal Viral Inactivation Method

  11/15/2005

• Biophage Pharma Inc. Announces New Development Breakthrough In Its PDS(R) Biosensors technology

  11/15/2005